Your browser doesn't support javascript.
loading
Senescence and senolysis in cancer: The latest findings.
Imawari, Yoshimi; Nakanishi, Makoto.
Affiliation
  • Imawari Y; Division of Cancer Cell Biology, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
  • Nakanishi M; Department of Surgery, Jikei University School of Medicine, Tokyo, Japan.
Cancer Sci ; 115(7): 2107-2116, 2024 Jul.
Article in En | MEDLINE | ID: mdl-38641866
ABSTRACT
Aging is a life phenomenon that occurs in most living organisms and is a major risk factor for many diseases, including cancer. Cellular senescence is a cellular trait induced by various genomic and epigenetic stresses. Senescent cells are characterized by irreversible cell growth arrest and excessive secretion of inflammatory cytokines (senescence-associated secretory phenotypes, SASP). Chronic tissue microinflammation induced by SASP contributes to the pathogenesis of a variety of age-related diseases, including cancer. Senolysis is a promising new strategy to selectively eliminate senescent cells in order to suppress chronic inflammation, suggesting its potential use as an anticancer therapy. This review summarizes recent findings on the molecular basis of senescence in cancer cells and senolysis.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cellular Senescence / Senescence-Associated Secretory Phenotype / Neoplasms Limits: Animals / Humans Language: En Journal: Cancer Sci Year: 2024 Type: Article Affiliation country: Japan

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cellular Senescence / Senescence-Associated Secretory Phenotype / Neoplasms Limits: Animals / Humans Language: En Journal: Cancer Sci Year: 2024 Type: Article Affiliation country: Japan